Keyword: Actavis

News

US States Sue Drugmakers Over Price-fixing

15.05.2019 - A coalition of 44 US states has filed a 500-page lawsuit against 20 leading generic drugmakers supplying the domestic market. The companies are accused of operating a sweeping...

News

UK Watchdog Finds Concordia Guilty of Market Abuse

30.11.2017 - In a provisional ruling announced on Nov. 21, the UK’s Competition and Markets Authority (CMA) has found that Canadian pharma Concordia abused its dominant position to overcharge...

News

Teva Cuts Jobs, Closes Plants as Woes Deepen

08.08.2017 - As its financial woes continue to deepen, Israeli generics producer Teva is making plans to lay off 7,000 employees and close 15 plants. CEO Yitzhak Peterburg said the company will...

News

UK Supreme Court Upholds Lily Alimta Patent

14.07.2017 - The UK Supreme Court has ruled in favor of US drugmaker Eli Lilly in a patent dispute with generics producer Actavis, now owned by Israel’s Teva, over the cancer drug Alimta. The...

News

Concordia and Actavis UK Accused of Overpricing

09.03.2017 - The UK’s Competition and Markets Authority (CMA) has accused Concordia and Actavis UK of breaking competition law by agreeing to delay competition and keeping the price of...

News

Teva Shareholders Criticize Generics CEO Switch

09.12.2016 - Shares of Israeli drugmaker Teva took a hit earlier this week when the company announced that its generics CEO, Siggi Olafsson, was leaving the company and would be replaced by...

News

Pfizer Loses Patent Appeal Against Allergan

17.10.2016 - Pifzer has lost its appeal of a UK patent dispute with Allergan over Lyrica, one of the US pharmaceutical giant blockbuster drugs, with annual global sales of around $5 billion. It...

News

Teva to Sell UK and Irish Assets to Accord Healthcare

07.10.2016 - Israel’s Teva Pharmaceutical Industries is planning to sell the assets of Actavis Generics in the UK and Ireland to Accord Healthcare, a subsidiary of India’s Intas Pharmaceuticals...